
Salts and Derivatives of Active Pharmaceutical Ingredients (API)
The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances.
At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.
Found 79283 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
3’-Hydroxy Warfarin
CAS:Controlled Product<p>Applications A new metabolite of Warfarin using Cunninghamella elegans.<br>References Wong, Y. W., et al.: J. Pharma. Sci., 80, 305 (1991)<br></p>Formula:C19H16O5Color and Shape:NeatMolecular weight:324.33N-Nitroso Fluvoxamine EP Impurity F Trifluoroacetic Acid
Formula:C17H25F3N4O3C2HF3O2Molecular weight:390.41 : 114.021-(2-(4-formyl-N-methylbenzamido)ethyl)piperidin-4-yl [1,1\'-biphenyl]-2-ylcarbamate
CAS:Formula:C29H31N3O4Molecular weight:485.58Lesinurad
CAS:Controlled Product<p>Applications Lesinurad is used to synthesize febuxostat which is a non-purine analog inhibitor of xanthine oxidase. Febuxostat is approved by the European Medicines Agency and the US Food and Drug Administration for treating gout.<br>References Burns, C., et al.: Lancet 377, 165 (2011); Miner, J. et al.: PCT Int. Appl. WO 2011159732 A1 20111222 (2011); Crittenden, D. B. et al.: Clinical Investigation 1, 1563-1575 (2011)<br></p>Formula:C17H14BrN3O2SColor and Shape:NeatMolecular weight:404.284-Ethoxycarbonyl-3-ethoxyphenylacetic Acid
CAS:Controlled Product<p>Applications Repaglinide intermediate.<br>References Wolfenbuttel, B., et al.: Eur. J. Clin. Pharmacol., 45, 113 (1993), Grell, W., et al.: J. Med. Chem., 41, 5219 (1998), Anon., et al.: Drugs Future, 24, 815 (1999),<br></p>Formula:C13H16O5Color and Shape:NeatMolecular weight:252.26

